Skip to content
Metabolic Root Cause — Houston

Neuropathy

Peripheral neuropathy is often treated as an irreversible neurological condition. But for many clients, it is a metabolic problem — the downstream consequence of insulin resistance damaging the small blood vessels that feed peripheral nerves. That changes what treatment can accomplish.

Board-Certified, ABIM
25+ Years Clinical Experience
4.8 Stars on Google
Understanding the Mechanism

Neuropathy is late-stage metabolic drift

Peripheral neuropathy — numbness, tingling, burning, or pain in the hands and feet — is conventionally classified as a neurological problem. The treatment follows that framing: medications that suppress the perception of nerve pain (gabapentin, pregabalin) without addressing what is damaging the nerves.

But for the majority of people with peripheral neuropathy who do not have another clear neurological cause, the root is metabolic. Peripheral nerves are dependent on very small blood vessels — called vasa nervorum — for their oxygen and nutrient supply. Chronic insulin resistance damages these microvessels through inflammatory and glycation-related mechanisms, compromising nerve blood flow. The nerve begins to lose function: first sensory changes, then pain, then progressive loss of sensation.

"Neuropathy is where the Drift concept becomes visible — it is the end expression of years of metabolic dysfunction that went unaddressed at the root."

This is not a question of whether you have diabetes. Many people develop metabolic neuropathy in the context of insulin resistance or prediabetes, long before glucose levels reach diabetic thresholds. The nerve damage has been accumulating during the years when standard labs appeared "normal."

BalanceMD advanced diagnostic exam room
The BalanceMD Approach

Addressing what is damaging the nerves — not just the pain signal

The Balance Method frames neuropathy as a branch on the metabolic tree. The trunk is insulin signaling and vascular health. The roots are the metabolic dysfunction that has been driving small vessel damage over time. Treating only the branch — with pain medications — leaves the damaging process active and allows progression to continue.

At BalanceMD, the evaluation asks: what is the metabolic environment that is damaging these nerves? Addressing insulin resistance, optimizing micronutrient status (particularly B12 and magnesium, which are essential for nerve function), reducing systemic inflammation, and normalizing metabolic signaling provides a foundation for halting progression and — depending on the duration and severity — potential partial recovery.

Conventional Approach

Symptom Management

  • Gabapentin or pregabalin to reduce pain perception
  • Condition described as progressive and irreversible
  • Glucose monitoring if diabetic
  • No investigation of metabolic drivers in non-diabetic neuropathy
The BalanceMD Approach

Root Cause Evaluation

  • Insulin resistance assessment — the primary metabolic driver
  • Micronutrient evaluation: B12, magnesium, D3
  • Inflammatory marker assessment to identify ongoing damage
  • Metabolic recalibration to halt progression and support nerve recovery
Signs & Symptoms

Who should have a metabolic evaluation for neuropathy

These presentations suggest peripheral neuropathy that may have a metabolic root — and may benefit from a comprehensive metabolic workup rather than symptom-only treatment.

Numbness or tingling in the feet, toes, or hands
Burning or electrical-feeling pain in the extremities
Symptoms that worsen at night or at rest
Neuropathy with insulin resistance, prediabetes, or metabolic syndrome
Neuropathy not fully explained by neurological evaluation
Currently on gabapentin or pregabalin with inadequate relief
Reduced balance or proprioception — difficulty sensing foot position
Family history of metabolic syndrome or type 2 diabetes
What to Expect

From metabolic evaluation to nerve protection

Neuropathy with a metabolic root requires a metabolic evaluation — one that goes well beyond what's been done before, and builds a treatment plan targeted at halting the underlying damage.

01

Comprehensive Evaluation

A thorough clinical assessment with Dr. Bryant covering the progression of your neuropathy, current medications, metabolic history, and relevant systems. This evaluation places your neuropathy in the context of your full metabolic and hormonal picture — identifying potential drivers that have not been addressed.

02

Targeted Lab Assessment

Labs are ordered separately and are typically covered by insurance. The panel evaluates insulin and metabolic status, micronutrient levels critical to nerve function (B12, magnesium, D3), inflammatory markers, and any other relevant contributors based on your clinical picture. This provides a precise metabolic map, not a routine workup.

03

Protocol to Address the Root

Your care plan directly targets the metabolic drivers identified — addressing insulin resistance through the Balance Spectrum nutritional framework, repleting deficient micronutrients, reducing systemic inflammation, and optimizing hormonal balance. The goal is to stop the damage at its source — and create the physiological conditions in which nerve recovery may occur.

Common questions about neuropathy

Whether neuropathy can be reversed depends significantly on what's causing it and how long it has been present. When the underlying driver is metabolic — specifically insulin resistance damaging the small blood vessels that feed peripheral nerves — addressing that root cause can halt progression and, in some cases, allow partial recovery of nerve function. The earlier intervention occurs, the greater the potential for improvement. Neuropathy that has been managed with symptom-only treatment for years without addressing the metabolic root has less reversal potential, but may still benefit from metabolic correction.
No — but metabolic dysfunction is the most common underlying cause, and diabetes is the most recognized form of metabolic dysfunction. Many people develop peripheral neuropathy in the context of insulin resistance, prediabetes, or metabolic syndrome, long before a formal diabetes diagnosis. Others have neuropathy driven by micronutrient deficiencies (particularly B12), inflammation, or autoimmune mechanisms. The important point is that the metabolic workup for neuropathy should be thorough — not limited to checking fasting glucose.
Peripheral nerves are fed by very small blood vessels called vasa nervorum. Chronic insulin resistance and elevated insulin levels damage these microvessels through a cascade of inflammatory and glycation-related mechanisms — even before glucose levels rise to diabetic thresholds. When the blood supply to a nerve is compromised, the nerve begins to lose function: first sensory changes (numbness, tingling), then pain, then potential motor involvement. Addressing insulin resistance is therefore not just about metabolic health — it directly protects peripheral nerve tissue.
The conventional approach to peripheral neuropathy focuses primarily on symptom management — gabapentin, pregabalin, and similar medications reduce the perception of nerve pain but do not address the underlying cause. This means the metabolic damage continues while the pain signal is muted. The BalanceMD approach asks: what is damaging these nerves, and can we stop it? For metabolically driven neuropathy, addressing insulin resistance, optimizing micronutrient status, and reducing systemic inflammation provides a foundation for halting — and potentially reversing — the nerve damage.

Ready to address the root cause of your neuropathy?

If your neuropathy has been managed with medication but never investigated at the metabolic level, there may be more that can be done. Schedule a free discovery call with Dr. Bryant.